Literature DB >> 9434272

Tetrafluoroethane (HFC 134A) propellant-driven aerosols of proteins.

A R Brown1, D W George.   

Abstract

PURPOSE: Develop metered-dose propellant-driven aerosols of proteins using tetrafluoroethane (HFC 134A) as propellant.
METHODS: Proteins were lyophilized with the propellant-soluble surfactants Triton X-100, Triton X-405, Laureth-9, Brij-30, Nonidet-40, and diethylene glycol monoethylether and then charged with propellants.
RESULTS: Small particle aerosols of the experimental protein bovine gamma globulin were produced. The fraction of aerosolized respirable-sized protein particles (< 4-5 microns) increased after dispersion of particles in propellant with agitation by shaking. Scanning electron microscopy of respirable-sized protein aerosols demonstrated bead-like particles in grape-like clusters. Vigorous shaking of propellant-suspended particles for 2 minutes or more reduced the size of clusters and reduced the diameters of the protein-containing subparticles that constituted the clusters. A 50:50 ratio of HFC 134A and dimethylether (DME) propellants improved the respirability of protein aerosols compared to HFC 134A as the sole propellant. Protein/surfactant particles first dispersed in DME and then diluted in HFC 134A propellant most efficiently produced respirable-sized, propellant-driven, protein aerosols.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434272     DOI: 10.1023/a:1012118132241

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Propellant-driven aerosols for delivery of proteins in the respiratory tract.

Authors:  A R Brown; J A Pickrell
Journal:  J Aerosol Med       Date:  1995

Review 2.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 3.  Generation of aerosolized drugs.

Authors:  R K Wolff; R W Niven
Journal:  J Aerosol Med       Date:  1994

Review 4.  An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).

Authors:  D J Alexander; S E Libretto
Journal:  Hum Exp Toxicol       Date:  1995-09       Impact factor: 2.903

5.  Propellant-driven aerosols of functional proteins as potential therapeutic agents in the respiratory tract.

Authors:  A R Brown; J G Slusser
Journal:  Immunopharmacology       Date:  1994 Nov-Dec

Review 6.  Metered dose inhaler therapy for asthma, bronchitis, and emphysema.

Authors:  J M Hofford
Journal:  J Fam Pract       Date:  1992-04       Impact factor: 0.493

7.  Vaccinator device for delivering propellant-driven aerosols of Streptococcus suis bacterin into the respiratory tracts of swine.

Authors:  A R Brown; D W George; D K Matteson
Journal:  Vaccine       Date:  1997-08       Impact factor: 3.641

8.  Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group.

Authors:  P Chervinsky; A van As; E A Bronsky; R Dockhorn; M Noonan; C LaForce; W Pleskow
Journal:  J Allergy Clin Immunol       Date:  1994-10       Impact factor: 10.793

9.  The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.

Authors:  J S Barton; H M Gardineri; S Cullen; P C Hindmarsh; C G Brook; M A Preece
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

10.  Chamber for testing metered-dose propellant-driven aerosols of immunologically relevant proteins.

Authors:  A R Brown; J A Pickrell
Journal:  J Immunol Methods       Date:  1994-12-02       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.